Serum adiponectin levels are associated with hepatitis B viral load in overweight to obese hepatitis B virus carriers

Obesity

Volumn 21, Issue 2, 2013, Pages 291-296

  Chiang, Chien Hsieh ^a,b   Lai, Jin Shin ^a,b   Hung, Shou Hung ^a   Lee, Long Teng ^a   Sheu, Jin Chuan ^a   Huang, Kuo Chin ^a,b,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALANINE AMINOTRANSFERASE; CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTHROPOMETRY; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GENDER; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OBESITY; PROTEIN BLOOD LEVEL; RISK FACTOR; TAIWAN; VIRUS LOAD; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; INSULIN; INSULIN RESISTANCE; LINEAR MODELS; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; OVERWEIGHT; RISK FACTORS; TAIWAN; VIRAL LOAD; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84876222535     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20000     Document Type: Article

References (30)

1. Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009;373:582-592.
2. Liu CJ, Chen PJ, Lai MY, et al. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 2003;124:80-90.
3. Marra F, Bertolani C. Adipokines in liver diseases. Hepatology 2009;50:957-969.
4. Kaser S, Moschen A, Kaser A, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med 2005;258:274-280. (Pubitemid 41243060)
5. Liu CJ, Chen PJ, Lai MY, et al. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. Hepatol Int 2009;3: 364-370.
6. Lu JY, Chuang LM, Yang WS, et al. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Liver Int 2005;25:752-759.
7. Mohamadkhani A, Sayehmiri K, Ghanbari R, Elahi E, Poustchi H, Montazeri G. The inverse association of serum HBV DNA level with HDL and adiponectin in chronic hepatitis B infection. Virol J 2010;7:228.
8. Siagris D, Vafiadis G, Michalaki M, et al. Serum adiponectin in chronic hepatitis C and B. J Viral Hepat 2007;14:577-583. (Pubitemid 47075433)
9. Yoon S, Jung J, Kim T, et al. Adiponectin, a downstream target gene of peroxisome proliferator-activated receptor gamma, controls hepatitis B virus replication. Virology 2010;409:290-298.
10. Wong VW, Wong GL, Yu J, et al. Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. Am J Gastroenterol 2009;105:132-138.
11. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
13. Kumar M, Choudhury A, Manglik N, et al. Insulin resistance in chronic hepatitis B virus infection. Am J Gastroenterol 2009;104:76-82.
14. Chu CJ, Hung TH, Hwang SJ, et al. Association of insulin resistance with hepatic steatosis and progression of fibrosis in Chinese patients with chronic hepatitis C. Hepatogastroenterology 2008;55:2157-2161.
15. McManus DD, Lyass A, Ingelsson E, et al. Relations of circulating resistin and adiponectin and cardiac structure and function: The Framingham Offspring Study. Obesity, (silver spring) 2012;20:1882-1886.
16. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2009;302:179-188.
17. Lu JY, Huang KC, Chang LC, et al. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond. J Biomed Sci 2008;15:565-576.
18. Kuo SM, Halpern MM. Lack of association between body mass index and plasma adiponectin levels in healthy adults. Int J Obes (Lond) 2011;35:1487-1494.
19. Lin YC, Yen LL, Chen SY, et al. Prevalence of overweight and obesity and its associated factors: findings from National Nutrition and Health Survey in Taiwan, 1993-1996. Prev Med 2003;37:233-241.
20. Chu NF. Prevalence of obesity in Taiwan. Obes Rev 2005;6:271-274.
21. Huang KC. Obesity and its related diseases in Taiwan. Obes Rev 2008;9(Suppl 1): 32-34.
22. Yen SL, Chiu TY, Lin YC, Lee YC, Lee LT, Huang KC. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Int J Obes (Lond) 2008;32:474-480.
23. Shlomai A, Shaul Y. The ''metabolovirus'' model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses 2008;71:53-57.
24. Chen CJ, Yang HI, Iloeje UH. Hepatitis B virus DNA levels and outcomes in chronic hepatitis B. Hepatology 2009;49:S72-84.
25. Yang HI, Lu SN, Liaw YF, et al. Hepatitis B e antigen and the risk of hepatocellular carcinoma. N Engl J Med 2002;347:168-174.
26. Chiang CH, Lai JS, Sheu JC, Yen LL, Liu CJ, Huang KC. The risky body mass index ranges for significant hepatitis B viral load: a campus-based study. Obes Res Clin Pract 2012;6:e31-e38.
27. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology 2009;50: 1392-1402.
28. Chen CJ, Yang HI, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 2006;295: 65-73. (Pubitemid 43042691)
29. Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130: 678-686. (Pubitemid 43374518)
30. Ni YH, Huang LM, Chang MH, et al. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies. Gastroenterology 2007;132:1287-1293.